(Q47823500)

5 February 2018

title

Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain (English)

1 reference

5 February 2018

1 reference

Itzhak Y

1

1 reference

5 February 2018

Ali SF

series ordinal

2

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

5 February 2018

Annals of the New York Academy of Sciences

published in

1 reference

5 February 2018

volume

844

1 reference

5 February 2018

page(s)

245-251

1 reference

5 February 2018

Hallucinogens of Plant Origin

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

Cerebral Pharmacokinetics of Tremor-Producing Harmala and Iboga Alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

A preliminary investigation of ibogaine: case reports and recommendations for further study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08239.X

10.1111/J.1749-6632.1998.TB08239.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9668682

1 reference

5 February 2018